Slide 1: Sharewise Webinar Presentation
ASX Announcement 8 July 2026 SHAREWISE WEBINAR PRESENTATION Mach7 Technologies Limited (“Mach7” or the “Company”) (ASX:M7T), a healthcare software company that enables health systems to securely store, access and share diagnostic images across disparate systems, provides a copy of a presentation tha
Slide 2: Introducing Mach7
For personal use only Introducing Mach7 Sharewise Conference 8 July 2026 Mach7 Technologies | ASX: M7T
Slide 3: Our Vision
OUR VISION For personal use only To be the global imaging EMR. We win by completing the patient picture with the patient’s pictures, better than anyone else. Pixels to point of care. * EMR (Electronic Medical Record): the core clinical software system used by hospitals.
Slide 4: Key industry trends
Key industry trends For personal use only Workforce and Interoperability & Cybersecurity Cloud and remote automation data integration and resilience workflows Open APIs and EMR Security is now Shortages in medical interoperability are Hybrid cloud and edge essential for staff drive adoption of criti
Slide 5: Expanded product suite
Expanded product suite eUnity Enterprise Vendor Neutral Archive Flamingo Architecture For personal use only Diagnostic Viewer ✓ Consolidate ALL images across the enterprise ✓ AI enablement within the software plus platform ✓ Zero footprint HTML-5 viewer; 100% fidelity ✓ Modular and flexible for crea
Slide 6: Differentiators
Differentiators For personal use only End-to-end modular architecture for data independence & sovereignty 1 Vendor Neutral Architecture allows customers full control and unrestricted access to their data, with modular components. AI & workflow automation drives advanced orchestration 2 Intelligent r
Slide 7: H1 FY26 Financial Review
H1 FY26 Financial Review Predominantly recurring revenue, lower cost base, strong balance sheet For personal use only 1 Recurring revenue base represents 85% of total revenue, 78% OPEX. 32% 2 Reduced operating expenses by 6% 10% 3 Strong financial position with cash of A$18.5M and no debt providing
Slide 8: Moving from archive to architecture
Moving from archive to architecture Executing deliberate transition, positioning imaging as core layer of patient record. For personal use only Clear Disciplined Rebuilt Sharpened operating cost commercial product model base engine roadmap Foundations for durable profitable growth in place. 7
Slide 9: Execution focus areas going into FY27
Execution focus areas going into FY27 For personal use only 1 2 3 4 5 Sales momentum Delivery execution Partner leverage Leadership and Cost and structural Improving with structured Execution improving and Expanding paths to organisational readiness pipeline. timelines shortening via markets, growth
Slide 10: Contact Us
For personal use only Contact Us Investor Relations, Mach7 Françoise Debelak Dixon +61 (0) 412 292 977 ir@mach7t.com Registered Office: Suite 2, Level 11, 385 Bourke St, Melbourne, VIC 3000 This document was authorised for release to the ASX by Teri Thomas, Managing Director and Chief Executive Offi
Slide 11: Disclaimer
Disclaimer “Forward looking” statements Summary of information: This presentation contains general and background information about Mach7 Risks: An investment in M7T securities is subject to investment and other known and unknown risks, Technologies Limited (“M7T”) activities current as at the date